Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 12, 2020 - Issue
Submit an article Journal homepage
108
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Budget Impact Analysis of Switching to Rituximab’s Biosimilar in Rheumatology and Cancer in 13 Countries Within the Middle East and North Africa

Ammar Almaaytah1 Faculty of Pharmacy, Middle East University, Amman, Jordan;2 Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, JordanCorrespondence[email protected]
View further author information
Pages 527-534 | Published online: 15 Sep 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.